Literature DB >> 23607257

Marginal zone lymphomas with monocytoid morphology express T-bet and are associated with a low number of T cells in extranodal locations.

Philipp Lohneis1, Stephan Wienert, Frederick Klauschen, Andrea Ullrich, Ioannis Anagnostopoulos, Korinna Jöhrens.   

Abstract

The presence of tumor cells with monocytoid morphology in marginal zone lymphoma (MZL) has been described previously. Reactive monocytoid B cells bear a distinct immunophenotype and typically express T-bet, which clearly distinguishes them from nodal marginal zone B cells. The latter are positive for CD27 and negative for T-bet. We analyzed 74 MZLs for the expression of T-bet and correlated these results with the presence of monocytoid morphology. Expression of T-bet correlated with the presence of monocytoid morphology in MZLs. In analogy to reactive monocytoid B lymphocytes, we also found a significantly lower relative amount of intratumoral T lymphocytes in extranodal MZL with monocytoid morphology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23607257     DOI: 10.3109/10428194.2013.797082

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses.

Authors:  Luciano Cascione; Andrea Rinaldi; Alessio Bruscaggin; Chiara Tarantelli; Alberto J Arribas; Ivo Kwee; Lorenza Pecciarini; Afua A Mensah; Valeria Spina; Elaine Y L Chung; Lodovico Terzi di Bergamo; Stephan Dirnhofer; Alexandar Tzankov; Roberto N Miranda; Ken H Young; Alexandra Traverse-Glehen; Gianluca Gaidano; Steven H Swerdlow; Randy Gascoyne; Raul Rabadan; Maurilio Ponzoni; Govind Bhagat; Davide Rossi; Emanuele Zucca; Francesco Bertoni
Journal:  Haematologica       Date:  2019-04-24       Impact factor: 9.941

2.  Relevance of Additional Immunohistochemical Markers in the Differential Diagnosis of Small B-Cell Lymphomas: A Case-Control Study

Authors:  Hale Kıvrak; Seher Yüksel; Can Ateş; Mustafa Merter; Gülşah Kaygusuz; Muhit Özcan; Işınsu Kuzu
Journal:  Turk J Haematol       Date:  2021-10-08       Impact factor: 2.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.